Ozempic vs Wegovy: what the labels say

Ozempic and Wegovy contain the same active ingredient, semaglutide. They differ in what they are approved for, how high the dose goes and how the pens work. Ozempic is approved for adults with type 2 diabetes and goes up to 2 mg a week.1 Wegovy is approved for weight reduction and related uses, with a recommended maintenance dose of 2.4 mg a week.2 This page reports the two labels. It does not tell you which to take.

Ozempic and Wegovy side by side

ItemOzempicWegovy
Active ingredientSemaglutide1Semaglutide2
Approved forAdults with type 2 diabetes: blood sugar control, and lowering certain heart and kidney risks1Weight reduction, lowering cardiovascular risk in certain adults, and a liver condition called MASH2
AgesAdults1Adults. Injection also from age 12 for weight reduction2
Starting dose0.25 mg weekly for 4 weeks10.25 mg weekly for 4 weeks2
Maintenance doses0.5 mg, 1 mg or 2 mg weekly12.4 mg (recommended) or 1.7 mg weekly2
Highest dose2 mg weekly17.2 mg weekly, for some adults2
FormsMulti-dose pens; single-dose prefilled syringes1Single-dose pens and syringes; a multi-dose FlexTouch pen; daily tablets2
Missed doseTake within 5 days, otherwise skip1Take if the next dose is more than 2 days away, otherwise skip2

What each is approved for

Ozempic

All three uses are for adults with type 2 diabetes.1

  • With diet and exercise, to improve blood sugar control.
  • To lower the risk of major cardiovascular events in those with established cardiovascular disease.
  • To lower the risk of worsening kidney function, kidney failure and cardiovascular death in those with chronic kidney disease.

Wegovy

  • Weight reduction and keeping weight off: adults with obesity, adults with overweight and at least one weight-related condition, and, for the injection, patients aged 12 and older with obesity.2
  • Lowering the risk of major cardiovascular events in adults with established cardiovascular disease and obesity or overweight.2
  • For the injection only: a liver condition called MASH with moderate to advanced fibrosis, in adults.2

Weight reduction is not among the uses on the Ozempic label.1

The dose schedules compared

Weekly injection doses by week: the earliest timing each label allows. Your prescriber decides whether and when to move between doses.
WeeksOzempicWegovy injection
1 to 40.25 mg0.25 mg
5 to 80.5 mg0.5 mg
9 to 120.5 mg or 1 mg1 mg
13 to 160.5 mg, 1 mg or 2 mg1.7 mg
17 onward0.5 mg, 1 mg or 2 mg2.4 mg or 1.7 mg
  • The first eight weeks match. Both labels give 0.25 mg for 4 weeks, then 0.5 mg.1, 2
  • Ozempic can stop at any maintenance dose. Increases to 1 mg and then 2 mg each come after at least 4 weeks, and the maintenance dose is chosen based on blood sugar control.1
  • Wegovy keeps stepping. It moves through 1 mg and 1.7 mg to a maintenance dose from week 17. If a step is not tolerated, the label says to consider delaying the next one by 4 weeks.2
  • Wegovy HD. Adults using Wegovy for weight reduction may go to a maximum of 7.2 mg weekly, after tolerating 2.4 mg for at least 4 weeks, if more weight reduction is clinically indicated.2

Wegovy tablets have their own daily schedule, from 1.5 mg up to 25 mg.2 Full charts: Ozempic, Wegovy, or both with a units table.

Can one stand in for the other?

The ingredient is the same, so a milligram of semaglutide is a milligram in either. The labels still treat them as separate products.

  • Neither label gives instructions for converting or switching between Ozempic and Wegovy.1, 2
  • The Wegovy label does not recommend using it together with other semaglutide-containing products.2
  • The pens deliver different set doses. No Ozempic pen is listed as delivering 1.7 mg or 2.4 mg, and no Wegovy pen is listed as delivering 2 mg.1, 2

Whether to move from one to the other, and at what dose, is a decision for a prescriber.

The pens

From section 3 of each label.
ProductStrengthWhat it delivers
Ozempic pen2 mg / 3 mL0.25 mg or 0.5 mg doses1
Ozempic pen4 mg / 3 mLFour 1 mg doses1
Ozempic pen8 mg / 3 mLFour 2 mg doses1
Wegovy single-dose pen0.25, 0.5 or 1 mgOne dose in 0.5 mL2
Wegovy single-dose pen1.7, 2.4 or 7.2 mgOne dose in 0.75 mL2
Wegovy FlexTouch pen9.6 mg / 3 mLFour 2.4 mg doses2

Both labels also list single-dose prefilled syringes.1, 2 All of these deliver set doses in milligrams, so there are no syringe units to work out. If you have semaglutide in a vial instead, see the semaglutide mg to units chart.

Both labels say never to share a multi-dose pen with another person, even with a new needle.1, 2

Missed doses

  • Ozempic: take the missed dose as soon as possible within 5 days. After 5 days, skip it and take the next dose on the regular day.1
  • Wegovy injection: if the next dose is more than 2 days away, take the missed dose as soon as possible. If it is less than 2 days away, skip it.2
  • Wegovy, two or more doses missed in a row: the label says to restart the escalation at a lower dose. That is a decision for your prescriber.2
  • Changing the day: the Ozempic label allows it if two doses are at least 2 days (more than 48 hours) apart.1 The Wegovy label says to inject on the same day each week.2

Storage

  • Ozempic pen: in the refrigerator at 2°C to 8°C (36°F to 46°F) before first use. After first use, usable for 56 days at room temperature (15°C to 30°C) or in the refrigerator.1
  • Wegovy single-dose pen: in the refrigerator at 2°C to 8°C. Before the cap is removed, it can be kept at 8°C to 30°C (46°F to 86°F) for up to 28 days.2
  • Wegovy FlexTouch pen: in the refrigerator before first use. After first use, usable for 56 days at 15°C to 30°C or in the refrigerator.2
  • Both: do not freeze, and do not use a pen that has been frozen.1, 2

Warnings they share

Both labels carry a boxed warning about thyroid C-cell tumors, which semaglutide causes in rodents; whether it does so in humans is unknown. Both are contraindicated for people with a personal or family history of medullary thyroid carcinoma or with MEN 2, and for people who have had a serious allergic reaction to semaglutide.1, 2

Nausea, vomiting, diarrhea, abdominal pain and constipation are among the most common side effects on both labels.1, 2 This is not the full safety information. Read the Medication Guide that comes with your prescription.

Questions

Are Ozempic and Wegovy the same drug?

They contain the same active ingredient, semaglutide. They are separate products with different approved uses, different doses and different pens.

What is the difference between Ozempic and Wegovy doses?

Both start at 0.25 mg once a week. The Ozempic label lists maintenance doses of 0.5 mg, 1 mg or 2 mg. The Wegovy label lists 2.4 mg or 1.7 mg, and allows 7.2 mg for some adults.

Is Ozempic approved for weight loss?

The Ozempic label lists three uses, all for adults with type 2 diabetes. Weight reduction is not one of them. Weight reduction is on the Wegovy label.

Is 2 mg of Ozempic the same as 2.4 mg of Wegovy?

No. They are different amounts of the same ingredient, and neither label gives a conversion between the two products.

Can you use Ozempic and Wegovy together?

The Wegovy label does not recommend using it together with other semaglutide-containing products.

Can you switch between Ozempic and Wegovy?

Neither label gives instructions for switching between the two. That is a decision for your prescriber.

Which one comes as a tablet?

The Wegovy label covers a once-daily tablet as well as the weekly injection. The Ozempic label covers injections only.

Can teenagers use Ozempic or Wegovy?

The Wegovy injection is approved for weight reduction in patients aged 12 and older with obesity. The Ozempic label says safety and efficacy have not been established in pediatric patients.

Does this page tell me which one to take?

No. It reports what the two FDA labels say. Which medicine and dose suit you is a decision for your prescriber.

Sources

  1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information, revised 05/2026, as posted by the FDA. accessdata.fda.gov (PDF) (opens in a new tab)
  2. Novo Nordisk. Wegovy (semaglutide) injection and tablets prescribing information, revised 06/2026, as posted by the FDA. accessdata.fda.gov (PDF) (opens in a new tab)
  3. Formulas and test cases: how the calculator math works.